What are the Challenges in Toxicological Testing of Biosimilars?
The challenges in toxicological testing of biosimilars stem from their large and complex structures, which can make traditional small-molecule testing methods inadequate. Advanced analytical techniques and biologic-specific assays are often required to assess the biosimilar's behavior in the body. Additionally, the variability in patient populations and treatment regimens can complicate the interpretation of toxicological data.
